NeurologyLive® Friday 5 — February 21, 2025

Author(s):

NeurologyLive® Staff

Key Takeaways

Holistic care in NMOSD management is crucial for improving patient quality of life beyond relapse prevention.
Genetic influences in ALS are a focus at the MDA Clinical & Scientific Conference, offering insights for neuromuscular specialists.
Stem cell approaches in epilepsy present both promising innovations and significant challenges in neurosurgical treatment.
AI integration and emerging therapies are transforming neurology, particularly in Parkinson's disease management.
Advances in stroke care were highlighted at the 2025 International Stroke Conference, showcasing future directions in the field.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 21, 2025.

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Managing NMOSD Disease Progression Through Healthy Habits and Holistic Care: Tammy Smith, MD, PhD

The assistant professor in the neurology department at the University of Utah in Salt Lake City discussed the importance of addressing broader quality-of-life measures in patients with NMOSD beyond just preventing relapses. [WATCH TIME: 3 minutes]

2: Advancing Therapeutic Knowledge of Genetic Influence in ALS: Matthew B. Harms, MD

The associate professor of neurology at Columbia University gave clinical insight on what neurologists and other neuromuscular specialists can expect from the ALS/frontotemporal dementia track at this year’s MDA Clinical & Scientific Conference. [WATCH TIME: 3 minutes]

3: Stem Cells in Epilepsy: Innovations and Challenges in Neurosurgical Treatment

Jonathon Parker, MD, PhD, an assistant professor of neurosurgery and neuroscience at Mayo Clinic Arizona, provided commentary on the promise and roadblocks behind stem cell approaches in epilepsy.

4: NeuroVoices: Sheryll Baltazar, NP-C, on AI Integration and Emerging Therapies in Neurology

The movement disorder nurse practitioner at Stony Brook Medicine talked about the growing role of artificial intelligence in neurology and emerging treatments for Parkinson disease.

5: Lessons Learned From the 2025 International Stroke Conference: Keith Churchwell, MD, FAHA, FACC, FACP

The president of the American Heart Association provided post-conference commentary on the advances shaping stroke care and excitement behind this year’s International Stroke Conference. [WATCH TIME: 3 minutes]